| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/17/2009 | WO2009151613A1 Oxybutynin derivatives |
| 12/17/2009 | WO2009151330A1 Nutritional composition for infants delivered via caesarean section |
| 12/17/2009 | WO2009151315A1 Nutritional composition for infants delivered via caesarean section |
| 12/17/2009 | WO2009150137A2 Organic compounds |
| 12/17/2009 | WO2009134917A3 Methods for treating inflammation |
| 12/17/2009 | WO2009100331A3 Compositions methods and kits for enhancing immune response to a respiratory condition |
| 12/17/2009 | WO2009046834A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 12/17/2009 | WO2009043481A3 Use of adrenomedullin 13-52 and optionally retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009043439A3 Use of retrocyclin- 1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009043437A3 Use of t140 and optionally retrocyclin-1 as therapeutic agents for the treatment of m. tuberculosis infections |
| 12/17/2009 | WO2009040072A3 Use of angiotensin i as a therapeutic agent in the treatment of eg aids or tuberculosis |
| 12/17/2009 | WO2009040071A3 Use of cyclo-rgdfv and optionally angiotensin i as therapeutic agents in the treatment of eg aids or tuberculosis |
| 12/17/2009 | WO2009040029A3 Use of adrenomedullin as a therapeutic agent for the treatment of excessive angiogenesis |
| 12/17/2009 | WO2009040028A3 Use of casoxin c and optionally adrenomedullin as therapeutic agents for the treatment of excessive angiogenesis |
| 12/17/2009 | WO2009039968A3 Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection |
| 12/17/2009 | WO2009039966A3 Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection |
| 12/17/2009 | WO2009039957A3 Use of angiotensin ii as a therapeutic agent in the treatment of eg s. pneumoniae infection |
| 12/17/2009 | WO2009033796A8 Use of a peptide as a therapeutic agent |
| 12/17/2009 | WO2009033707A3 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 12/17/2009 | WO2009033661A3 Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections |
| 12/17/2009 | WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss |
| 12/17/2009 | WO2008117229A4 Muscarinic receptor antagonists |
| 12/17/2009 | WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312430 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | US20090312423 Therapeutic treatment for lung conditions |
| 12/17/2009 | US20090312398 Compositions and their uses directed to il-4r alpha |
| 12/17/2009 | US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors |
| 12/17/2009 | US20090312319 Certain chemical entities, compositions and methods |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312307 Heterocyclo inhibitors of potassium channel function |
| 12/17/2009 | US20090311235 Use of Polymeric Materials with Other Substances for Improved Performance |
| 12/17/2009 | US20090311231 Product and process for liquefaction of mucus or sputum |
| 12/17/2009 | CA2727196A1 Organic compounds |
| 12/16/2009 | EP2133359A2 Recombinant haemophilus influenzae adhesin proteins |
| 12/16/2009 | EP2133353A1 Novel adenine compound |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133089A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes |
| 12/16/2009 | EP2133083A1 Therapeutic agent for infectious skin or mucosal disease |
| 12/16/2009 | EP2132196A1 Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 12/16/2009 | EP2132189A1 Salts of a selective beta-2 andrenoceptor agonist |
| 12/16/2009 | EP2132169A1 New methylenebisphenyl compounds useful in the treatment of inflammation |
| 12/16/2009 | EP2131853A1 Methods and compounds for modulating inflammatory processes |
| 12/16/2009 | EP2131829A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants |
| 12/16/2009 | EP1904057B1 Hydroquinone ansamycins in the treatment of gastrointestinal stromal tumors |
| 12/16/2009 | CN101605814A Engineered anti-TSLP antibody |
| 12/16/2009 | CN101605791A 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
| 12/16/2009 | CN101605789A Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor |
| 12/16/2009 | CN101605784A Aza-bridged-ring compound |
| 12/16/2009 | CN101605770A Salts 668 |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101601855A Analysis method of Guilong kechuangning tablet |
| 12/16/2009 | CN101601846A Preparation method of heracleum hemsleyanum michaux and herba artemisiae capillaris oral wine |
| 12/16/2009 | CN101601830A Chinese medicinal preparation for treating cold and preparation method thereof |
| 12/16/2009 | CN101601822A Medicament for treating infantile cough and laryngeal stridor and preparation method thereof |
| 12/16/2009 | CN101601816A Chinese medicament for treating asthma |
| 12/16/2009 | CN101601807A Preparation method of medicine for rapidly curing aphonia |
| 12/16/2009 | CN101601806A Preparation method of ointment for clearing lung and nourishing yin |
| 12/16/2009 | CN101601805A Method for detecting peimine and peiminine in Chinese medicament fritillaria extract |
| 12/16/2009 | CN101601803A Preparation method of anti-cough liquid |
| 12/16/2009 | CN101601798A Preparation method of paris polyphylla saponin |
| 12/16/2009 | CN101601797A Patch for treating chronic bronchitis and manufacturing method thereof |
| 12/16/2009 | CN101601787A Composition for treating bronchial asthma and preparation method thereof |
| 12/16/2009 | CN101601775A Externally-applied traditional Chinese medicine preparation for curing cardio-cerebral respiratory circulatory system diseases and preparation method thereof |
| 12/16/2009 | CN101601764A Pharmaceutical composition that contains eucalyptus and orange oil |
| 12/16/2009 | CN101601755A Double-face external patch for treating chronic bronchitis |
| 12/16/2009 | CN101601754A Method for preparing Qingkailing capsules |
| 12/16/2009 | CN101601735A Patch for treating hypertension and manufacturing method thereof |
| 12/16/2009 | CN101601728A Traditional Chinese medicine composition for treating common cold and preparation method thereof |
| 12/16/2009 | CN101601716A Patch for treating chronic bronchitis |
| 12/16/2009 | CN101601665A Use of 1r, 2s-methoxamine in preparing medicament for treating faecal incontinence and other conditions |
| 12/16/2009 | CN100569796C Immune modulating peptide |
| 12/16/2009 | CN100569770C 5-phenylthiazole derivatives and their use as PI3 kinase inhibitors |
| 12/16/2009 | CN100569760C Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569255C Nitric oxide and its biomedical significance |
| 12/16/2009 | CN100569251C Quality control method of cough-stopping (Ke Ke) capsule |
| 12/16/2009 | CN100569235C Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD |
| 12/16/2009 | CN100569114C Crocodile meat preparation and production process thereof |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/15/2009 | US7632844 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors |
| 12/15/2009 | CA2423354C Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications |
| 12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 12/15/2009 | CA2334189C Bridged indenopyrrolocarbazoles |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/15/2009 | CA2259185C High dose liposomal aerosol formulations |
| 12/10/2009 | WO2009148137A1 Nucleic acid capable of controlling degranulation of mast cell |
| 12/10/2009 | WO2009147742A1 Sirna of human osteopontin |
| 12/10/2009 | WO2009147476A1 Novel pde inhibitors, pharmaceutical compositions containing them and processes for their preparation |
| 12/10/2009 | WO2009147442A1 Novel treatments |
| 12/10/2009 | WO2009147383A1 Process for the synthesis of arformoterol |
| 12/10/2009 | WO2009147218A1 Pharmaceutical combination |
| 12/10/2009 | WO2009147190A1 Novel compounds |
| 12/10/2009 | WO2009147189A1 Novel compounds |
| 12/10/2009 | WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 12/10/2009 | WO2009146807A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms |
| 12/10/2009 | WO2009126682A3 Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |